Two Sigma Securities, LLC Geo Vax Labs, Inc. Transaction History

Two Sigma Securities, LLC

  • $5.78 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023
BUY
$0.55 - $0.75 $11,393 - $15,537
20,716 Added 128.76%
36,805 $20,000
Q1 2023

May 15, 2023
BUY
$0.62 - $1.11 $9,975 - $17,858
16,089 New
16,089 $10,000
Q4 2021

Feb 14, 2022
SELL
$52.65 - $71.7 $599,314 - $816,161
-11,383 Closed
0 $0
Q3 2021

Nov 15, 2021
BUY
$56.4 - $91.35 $642,001 - $1.04 Million
11,383 New
11,383 $49,000

About GeoVax Labs, Inc.

GOVX Quotes by TradingView
  • Ticker GOVX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 24,744,000
  • Market Cap $73M
  • Description
  • GeoVax Labs, Inc., a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and cancers using modified vaccinia ankara virus-like particle vaccine platform. It is developing various preventive vaccines against (COVID-19), human immunodeficiency virus (HIV); Zika virus; malaria; and hemorrhag...
More about GOVX
Track This Portfolio

Track Two Sigma Securities, LLC Portfolio

Follow Two Sigma Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Securities, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email